Physician-Scientist at Texas Children’s Cancer Center Receives $486,000 Grant to Advance Research in Childhood Cancer
HOUSTON, Aug. 17 /PRNewswire-USNewswire/ -- Donald W. (Will) Parsons, M.D., a physician at Texas Children's Cancer Center and Baylor College of Medicine, has been honored with a 2010 Doris Duke Clinical Scientist Development Award. Dr. Parsons, who works in collaboration with Dr. Richard Gibbs at Baylor College of Medicine's Human Genome Sequencing Center, specializes...
A large study focused on documenting the strength and fitness of childhood brain tumor survivors has found that many face health challenges as they age. The study led by St. Jude Children's Research Hospital investigators showed that although most participants were young adults in their 20s, many functioned like people in their 60s, making them less likely to live independently or attend college.
For the past 20 years, pediatric patients battling neuroblastoma — a malignant tumor originating in the nervous system or adrenal gland — could undergo 3F8 Monoclonal Antibody Therapy only at Manhattan’s Memorial Sloan-Kettering Cancer Center. But thanks to a multicenter study that includes 14 hospitals nationwide, more patients will have access to the unique treatment for the childhood cancer.
Study found when woman's uterus, ovaries had been exposed at young age, risk was up to 12 times greater
By Steven ReinbergHealthDay Reporter
THURSDAY, July 22 (HealthDay News) -- Women who are childhood cancer survivors face a greater risk of having a stillborn child if their uterus or ovaries were exposed to radiation during their treatments, a new study finds.
Although neither boys nor girls who survived childhood cancer appear to suffer...
St. Jude scientists develop new genomics-based approach to understand the origin of cancer subgroups
Unique combinations of cells and mutations lie at the heart of cancer subgroup revealed for the first time in a pediatric brain tumor
MEMPHIS, Tenn., July 18, 2010 /PRNewswire/ — Scientists have long recognized that cancers may look the same under the microscope, but carry different mutations, respond differently to treatment and result in vastly different outcomes for patients....